NextCell Pharma AB (OSTO:NXTCL) Construction In Progress : kr11.69 Mil (As of May. 2024)

View and export this data going back to 2017. Start your Free Trial

What is NextCell Pharma AB Construction In Progress?

NextCell Pharma AB's quarterly construction in progress stayed the same from Nov. 2023 (kr11.63 Mil) to Feb. 2024 (kr11.63 Mil) but then increased from Feb. 2024 (kr11.63 Mil) to May. 2024 (kr11.69 Mil).

NextCell Pharma AB's annual construction in progress increased from Aug. 2021 (kr0.00 Mil) to Aug. 2022 (kr7.56 Mil) and increased from Aug. 2022 (kr7.56 Mil) to Aug. 2023 (kr11.59 Mil).

NextCell Pharma AB Construction In Progress Historical Data

The historical data trend for NextCell Pharma AB's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NextCell Pharma AB Construction In Progress Chart

NextCell Pharma AB Annual Data

Trend

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Construction In Progress

Get a 7-Day Free Trial

7.56

11.59

NextCell Pharma AB Quarterly Data
	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24
Construction In Progress	Get a 7-Day Free Trial															11.23	11.59	11.63	11.63	11.69

NextCell Pharma AB Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

NextCell Pharma AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NextCell Pharma AB (OSTO:NXTCL) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

65G:Germany

Address

Karolinska Institutet Science Park, Halsovagen 7, Huddinge, SWE, 14157

Website

http://www.nextcellpharma.com

NextCell Pharma AB is a healthcare services provider. The company is engaged in the research of stem cell and is developing the candidate drug ProTrans for the treatment of diabetes and immunosuppression in kidney transplants.

NextCell Pharma AB Headlines

No Headlines